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The necessity for
T-cryptantigen activation
screening in babies with
necrotising enterocolitis
G. F. Kirsten, J. Smith, C. Pieper, A. Bird,
G. Wessels, S. Riphagen, S. Maore
Objective. To detennine the prevalence of T-cryptantigen
activation (TeA) and its predictive value for severity of
necrotising enterocolitis (NEC) in babies.
Study design. Prospective descriptive.
Study population. Thirty-four babies with NEe were
prospectively screened for TeA at Tygerberg Hospital over
a 6-month period. TeA screening was done by testing for
red blood cell agglutination by the common peanut lectin,
Arachis hypogea. Once TeA was confirmed, only washed
red cells were administered to the babies and plasma-
containing blood products were avoided. NEe was divided
into suspected NEC (stage 1), classic NEC (stage 2) and
fulminant NEC (stage 3).
Main outcome measures. Prevalence of TeA in babies
with various stages of NEC; the association between TCA
and bowel necrosis, need for surgery and mortality.
Results. TeA was positive in 8 (24%) of the babies in
this study. Six babies (18%) had stage 1 NEC, 10 (29%)
had stage 2 NEC and 18 (53%) had fulminating or stage 3
NEC. All 18 babies with stage 3 NEC required surgery and
TeA was present in 8 (47%) of them. Twelve babies (35%)
died, 3 with TCA and g with no TCA. Babies with TCA had
portal venous gas on abdominal radiographs (P = 0.037)
and stage 3 NEC (P = 0.003) more often than babies with
no TCA.
Conclusions. A strong association was noted between
TCA and the fulminant form of NEe with bowel necrosis.
TCA in a baby with NEC should alert the surgeon to the
possibility of severe disease and the need to avoid
plasma-containing blood products.
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Blood banks are urged to introduce routine screening
for TCA in all babies with NEC.
S Afr Med J 1996; 86: 546-548.
It is often very difficult to determine early which babies with
necrotising enterocolitis (NEC) need surgery. T-cryptantigen
activation (TCA), which has been associated with the
fulminant form of NEC,' may therefore be important for its
predictive value in this regard. TeA's tendency to precipitate
acute intravascular haemolysis2 after plasma-containing
blood product transfusion has far-reaching implications for
the management of these babies. It therefore seems
essential that all babies with suspected NEC be screened
for TCA. Such routine screening was recently introduced at
Tygerberg Hospital in order to determine the prevalence of
TCA and its predictive value for outcome in babies with
NEC.
We report on the babies with NEC who were screened for
TCA over a 6-month period.
Patients and methods
All babies with NEC treated in the neonatal wards at
Tygerberg Hospital were prospectively screened for TeA
from August 1993 to January 1994.
NEC was diagnosed on the clinical picture of feeding
intolerance. abdominal distension, bloody stools and
radiological demonstration of pneumatosis intestinalis, or by
means of histological evidence of NEe in a surgical
pathology specimen. The severity of NEC was graded
according to the modified criteria of Bell (as modified by
Walsh and Kliegman)3 where stage 1 NEC constituted
suspected NEC, stage 2 classic NEC (the presence of
pneumatosis intestina/is on plain abdominal radiograph in a
moderately ill baby) and stage 3 fUlminating NEC with
peritonitis, perforation or portal venous gas on radiograph.
Once NEC was suspected, red cells from the babies were
tested for TCA. Blood samples from affected patients were
screened by testing for red blood cell agglutination with the
common peanut lectin, Arachis hypogea.' One drop of a
saline extract of this anti-T lectin (prepared from raw
unsalted shelled peanuts) is added to one drop of red cells,
mixed well and incubated at room temperature for 15
minutes. After centrifugation, the tubes are read macro- and
microscopically for agglutination. Positive controls (prepared
by treating fresh group 0 red blood cells with
neuraminidase) as well as negative controls are set up with
each test. Blood cultures were done in all patients while
peritoneal fluid cultures were done if appropriate. Initial
antibiotic management consisted of penicillin, amikacin and
metronidazole. Indications for surgical intervention included
the presence of bowel perforation, peritonitis or clinical
deterioration.
Patients with TCA were only given washed red cells;
plasma-containing blood products such as fresh-frozen
plasma were avoided.
Clotting abnormalities were managed with vitamin K,
cryoprecipitate and platelets when the platelet count was
< 40 x 10'n.
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Student's t-test and the chi-square test were used to
determine statistical significance (P ~ 0.05).
Results
Altogether 34 babies with NEC were diagnosed over a
6-month period. The mean birth weight of the babies was
1 416.3 g (range 655 - 3 240 g), mean gestational age 31.4
weeks (range 26 - 40 weeks) and mean onset of NEC 13
days (range 2 - 59 days). Six (18%) had stage 1, 10 (29%)
stage 2 and 18 (53%) stage 3 NEC. Twenty-two babies
(65%) survived. Eight babies (44%) with stage 3 NEC had
TCA while none with stages 1 and 2 was affected (sensitivity
44%, specificity 100%, positive predictive value 100%,
negative predictive value 62%). The clinical characteristics
and outcome of the babies with the various stages of NEC
are shown in Table I. All 18 babies with stage 3 NEC
required surgery within 24 hours because of the onset of
symptoms of acute peritonitis. In 3, abdominal drains were
inserted. Four of the 7 babies with stage 3 NEC who had
portal venous gas on abdominal radiographs had TCA, while
only 1 baby with NEC (TCA-negative) had radiological
evidence of free air in the abdomen. Bowel necrosis with
perforation occurred in all 8 babies with TCA and all required
surgery.
Table I. The characteristics and outcome of babies with various
stages of NEC
Stage Stage Slage All
1 2 3 patients
No. (%) 6 (18%) 10 (29%) 18 (53%) 34
Mean birth weight (g) 1188.3 1319 1546.1 1 416.3
Mean gestational age (wks) 30.7 30.6 32.0 31.4
Abdominal radiograph
Portal air 0 0 7 (39%) 7 (21%)
Free air in abdomen 0 0 1 (6%) 1 (3%)
Surgery
Laparotomy 0 0 15 (63%) 15 (44%)
Abdominal drain 0 0 3 (17%) 3(9%)
Positive blood culture 2 (33%) 3 (30%) 7 (39%) 12 (35%)
Babies with positive
blood culture who died 0 2 (66%) 3(43%) 5 (42%)
TCA-positive 0 0 8(44%) 8 (24%)
Mean age at onset of
NEC (d) 8.7 13.4 16.4 14.17
Died 0 3" (30%) 9 (50%) 12 (35%)
• One baby died from nosocomially acquired candida septicaemia at 3 weeks of age
Blood cultures were positive in 12 (35%) of the babies. Of
the babies with TCA, only 1 (13%) had a positive blood
culture (Enterobacter cloaca), while 11 (42%) babies without
TCA had positive blood cultures. Of these, 4 (33%) grew
Escherichia coli,S (42%) KlebsielJa pneumoniae, 1 a 0-
haemolytic streptococcus and 1 Staphylococcus epidermidis.
Three (37%) of the babies with TCA died, while 9 (35%)
with no TCA died. Of the 12 babies who died, 5 (41 %) (all
TCA-negative) had a positive blood culture. Another baby
died after 3 weeks from a nosocomially acquired candida
septicaemia.
The characteristics of the babies with and without TCA
are shown in Table 11.
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Table 11. Characteristics of babies with NEC and TCA v. no TCA
Characteristic TCA NoTCA P
Total 8 26
Mean birth weight (g) 1 750 1313 0.1475
(SO 748) (SO 294)
Mean gestational age (wks) 33.6 30.7 0.0544
(SO 3.6) (502.1)
Mean age at onset of NEC (d) 18.4 12.9 0.2997
(SO 15.0) (SO 12.2)
No. with stage 3 NEe 8 (100%) 10(38%) 0.003
No. with venous portal gas 4 3 0.037
No. with positive blood culture 1 11 0.210
Survivors 5 17 1.000
Survivors with stage 3 NEC 5 4 0.637
Babies with positive blood
cultures who died 0 5 1.000
Discussion
NEC is a common condition of premature babies affecting
approximately 12% of very-Iow-birth-weight infants5
« 1 500 g). The reported mortality rate ranges between 30%
and 40%, but may be as high as 80% in babies weighing
less than 1 000 g.5 The mortality rate is also directly related
to the severity of NEC and is highest in babies with stage 3
disease. Novak et al. 1 demonstrated a decrease in mortality
in babies with NEC after the introduction of routine
screening for TCA activation and the avoidance of
transfusion of plasma-containing blood products in TCA
babies. Given the bias towards more severely affected
infants in the TCA group, the 35% mortality rate in these
babies in the present series might have been even greater
had the use of plasma-containing products not been
avoided.
Thomsen-Friedenreich cryptantigens (T-cryptantigens) are
naturally occurring antigens normally concealed by
neuraminic acid in the sub-terminal layer of the red blood
cell membraneY Certain bacteria such as clostridia,
bacteroides, Streptococcus pneumoniae and certain viruses
produce neuraminidase which may destroy the neuraminic
acid on the surface of the red blood cells, thus exposing the
hidden cryptantigens - so-called TCA.~7 This renders the
red cells polyagglutinable when exposed to cryptantigen
antibodies. These antibodies are naturally acquired
haemagglutinins (lgM subclass) found in most humans after
the age of 6 months and are, therefore, present in most
plasma-containing blood products. r.B
TCA occurs in 11 - 34% of babies with severe NEC,r a
finding comparable to the 24% noted in the present series.
The strong association between TCA and a fulminant
course of NEC with bowel necrosis and a high risk of
intestinal perforation' was confirmed in our study: babies
with stage 1 and 2 NEC were TCA-negative, while 8 babies
with stage 3 NEC and TCA had bowel necrosis with
perforation. TCA in babies with NEC should alert the
surgeon to the severity of the disease and the probability of
early operative intervention.9
Intrahepatic portal venous gas in babies with NEC, as
demonstrated on abdominal radiograph, has been
associated with extensive bowel necrosis and a high
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mortality rate_2 Portal venous gas was present in 4 (50%) of
the babies wrth TCA and in 3 (12%) with no TCA. All these
patients were shown to have extensive bowel necrosis.
Three of the babies with TCA died (38%). Of these, 1 had
severe bronchopulmonary dysplasia (SPD) and died from
complications associated with SPD. The other 2 babies
were more mature (36 and 40 weeks). One developed
fulminating NEC after severe birth asphyxia and an
exchange transfusion for rhesus incompatibility, while the
other, referred to us on day 4, had bowel obstruction caused
by an undiagnosed imperforate anus.
Bacteria are associated with NEC, but their role is as yet
unclear.sAnaerobic bacteria such as clostridia are often
associated with a more fulminant disease course.sOne of
the babies with TCA had a positive blood culture, while a
variety of aerobic organisms was cultured from the blood of
the babies with no TCA.
No anaerobic bacteria were cultured from either the blood
or peritoneal fluid of any of the babies, despite correct
sample collection techniques. This may be related to the
great difficulty experienced by microbiology laboratories in
culturing anaerobes.ll Four of the babies (80%) with blood
cultures positive for Klebsiella died, even in the presence of
stage 2 NEC. The clinical course of these infants was
severely influenced by septicaemia-related complicatons,
especially pneumonia.
We advise that screening for TCA activation be performed
routinely in babies with NEC.2 The screening test is simple,
quick and inexpensive to perform." Arachis hypogea strongly
agglutinates T-activated red cells.'·1l
Positive tests should be quantified, as the degree of
activation correlates with the likelihood of haemolysis
following transfusion of plasma products as well as with the
severity of NEC.'
If the test is positive, the clinician should be informed so
that only washed red cells or platelets are used and
immunoglobulin-containing products such as plasma are
avoided.7
A major predicament is the need for plasma-derived
products in the resuscitation of infants with stage 3 NEC,
especially if their condition is complicated by an acquired
coagulopathy. These products contain cryptantibodies and
may precipitate massive intravascular haemolysis in infants
with TCA.'
General supportive measures, such as fluid replacement
using colloids or albumin for treatment of shock, are
advised. Specific treatment of the underlying condition is of
major importance and may be the only measure needed for
mild disseminated intravascular coagulation (DIG). If surgery
is planned or the patient is actively bleeding, repracement
transfusion therapy with washed red cells, platelets and ~f
available) cryoprecipitate may be undertaken. In infants with
severe DIC the safest measure is the transfusion of plasma
previously identified to have a low titre of cryptantibodies.'"
If this is not available we propose that a double-volume
exchange transfusion with washed cells suspended in
albumin or, if technically feasible, plasmapheresis using
albumin as replacement fluid, will be a more effective
method of treatment than transfusion with plasma~derived
(high cryptantibody titre) replacement products. If a baby
with TCA requires an exchange transfusion, the washed
erythrocytes should be suspended in 5% albumin. '2
Screening for TCA in babies should be undertaken
routinely when NEe is first suspected. It is important to
realise that TCA cannot be detected by standard cross-
matching techniques.'
In infants with NEC, TeA is transient and parallels the
course of the disease but may persist for as long as 120
days after resolution of NEC.7 For this reason screening
must be continued on a weekly basis until TCA is negative
and must be repeated prior to any plasma-containing blood
product transfusion.
In summary, this study confirms the strong association
between TCA, the fulminant form of NEC and bowel
necrosis. The finding of TCA in a baby with NEC should alert
the surgeon to the possibility of a severe degree of NEC
requiring surgery_ The administration of plasma-containing
blood products will further increase the morbidity and
possibly mortality of these babies. The routine screening for
TCA in babies with NEC should constitute an integral part of
their management.
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